step 7 semaglutide Once-weekly 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial How Long Has Semaglutide Been

Other reasons to wait are for the benefit of your health

Theyll take a deep dive into your unique health profile to figure out if this treatment is the right fit for you

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients

We look for things like diet, past illnesses, or family history of anemia

announced the decision to discontinue the development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist, which was being investigated for chronic weight management

If you have extreme obesity or obstructive sleep apnea (OSA), Zepbound may be a better option for you